My Clinical Trials

Question 1

RSP is the same as —-

Answer 1

CTLC

Question 2

BMBX means:

Answer 2

bone marrow biopsy

Question 3

CNF stands for:

Answer 3

case notification form (for Tissue Core notification samples)

Question 4

MCC 18926 disease:

Answer 4

MDS (Myelodysplastic Syndromes)

Question 5

MCC 19429 disease:

Answer 5

Myelofibrosis

Question 6

MCC 20331 disease:

Answer 6

MPN (Myeloproliferative Neoplasms)

Question 7

MCC 19737 study drug:

Answer 7

ruxolitinib

Question 8

Who is the PI for 18926?

Answer 8

Dr. Komrokji

Question 9

Who is the PI for 19737?

Answer 9

Dr. Onyee Chan

Question 10

Who is the PI for 20331?

Answer 10

Dr. Andrew Kuykendall

Question 11

My phone extension

Answer 11

745-7943

Question 12

For 18926, when do we collect Hair Follicles & Buccal Swabs?

Answer 12

Baseline and then optionally collected at M12 & M24.

Question 13

MCC 20331 status?

Answer 13

Suspended

Question 14

Name the 4 “closeout” studies from Caroline

Answer 14

19379, 20634, 19872, and 20061

Question 15

MCC 20634 status and patients?

Answer 15

Closed to Accrual, all pt’s off study. “Early termination of trial by sponsor”

Question 16

MCC 20061 status and patients?

Answer 16

Closed to Accrual, 3 patients on follow-up

Question 17

MCC 19379 status and patients?

Answer 17

Closed to Accrual, all pt’s off study

Question 18

MCC 19872 status and patients?

Answer 18

Closed to Accrual, 1 patient on follow up

Question 19

MCC 19872 study drug?

Answer 19

Luspatercept

Question 20

MCC 20061 study drug?

Answer 20

Vyxeos

Question 21

MCC 19429 P.I.?

Answer 21

Dr. Komrokji

Question 22

MCC 19872 sponsor and P.I.?

Answer 22

Acceleron and Celgene. Dr. Komrokji

Question 23

Which study used drug to prepare pt for transplant (induction)?

Answer 23

MCC 20061

Question 24

Which study evaluates which drug is most useful in reducing need for RBC transfusions?

Answer 24

MCC 19872

Question 25

"MMB vs. DAN in Symptomatic, Anemic Subjects w/ PMF, Myelofibrosis, or Post ET Myelofibrosis"

Answer 25

MCC 20634

Question 26

"A Pilot Study of Vyxeos for Transplant Eligible, Higher Risk Pt's w/ Myelodysplastic Syndrome"

Answer 26

MCC 20061

Question 27

"Luspatercept vs Epoetin Alfa for the Treatment of Anemia due to IPSS-R"

Answer 27

MCC 19872

Question 28

CTLC is the same as —-

Answer 28

RSP

Question 29

Name the 2 Caroline studies that have no follow up patients

Answer 29

19379 and 20634

Question 30

Name the 2 Caroline studies that have follow up patients

Answer 30

19872 and 20061

Question 31

"Navitoclax Alone or in Combination w/ Ruxolitinib in Subjects w/ Myelofibrosis"

Answer 31

MCC 19429

Question 32

MCC 19429 sponsor and study drug?

Answer 32

AbbVie and Navitoclax

Question 33

MCC 20061 sponsor and P.I.?

Answer 33

Jazz Pharmaceuticals and Dr. Sallman

Question 34

MCC 19737 disease:

Answer 34

CML (Chronic Myeloid Leukemia)

Question 35

MCC 19429 status and patients?

Answer 35

Closed to Accrual, 1 patient ON FOLLOW UP (final cert was in August?)